{"Clinical Trial ID": "NCT00003404", "Intervention": ["INTERVENTION 1:", "Adjuvant Radiotherapy", "The adjuvant radiation started within 12 weeks of local excision or reexcision of the breast.", "Adjuvant Radiotherapy: Radiotherapy Adjuvant"], "Eligibility": ["CHARACTERISTICS OF DISEASE:", "The histologically proven phyllode tumours of the breast with borderline or malignant grade, defined as 1 of the following:", "- Borderline, defined as 5-9 mitoses/10 high-power fields (HPF), pushing or infiltrating margins, 2+ atypy", "- Magnon, defined as 10 mitoses or more/10 HPF, mainly infiltrating margins, usually 3+ atypies with 2+ occasional atypies", "\u2022 Must have been excised with breast conservation resection and no positive margin", "Local recurrence of previously excised phyllode tumour if recurrence is within the area of anterior excision", "No anterior breast carcinoma or in situ ductal carcinoma in the ipsilateral breast", "\u2022 Hormonal receptor status: Unspecified", "CHARACTERISTICS OF PATIENTS:", "\u2022 Aged 18 years and over", "Gender: Female", "Status of menopause: Unspecified", "State of execution: Unspecified", "Life expectancy: Not specified", "Haematopoietic: Not specified", "Hepatic: Unspecified", "Dream: Unspecified", "Other:", "Not pregnant", "Negative pregnancy test", "Fertile patients should use effective contraception", "THERAPE PRIOR CONCURENT:", "Biological therapy: Not specified", "- Chemotherapy: Not specified", "Endocrinotherapy: Not specified", "Radiotherapy: No prior radiation therapy in the ipsilateral breast", "Surgery: See Disease Characteristics"], "Results": ["Performance measures:", "Local recurrence rate", "Local recurrence rate of phyllode tumours", "Time limit: 36 months after initial excision", "Results 1:", "Title of the arm/group: Adjuvant Radiotherapy", "Description of the arm/group: Adjuvant radiation began within 12 weeks of local excision or breast reexcision.", "Adjuvant Radiotherapy: Radiotherapy Adjuvant", "Total number of participants analysed: 46", "Type of measure: Number of participants", "Unit of measure: Participants 0 0.0%"], "Adverse Events": ["Undesirable Events 1:", "Total: 0/46 (0.00 per cent)"]}